T1	Participants 0 79	Poor prognosis patients with inoperable locally advanced NSCLC and large tumors
T2	Participants 199 287	Poor prognosis patients with bulky stage III locally advanced non-small-cell lung cancer
T3	Participants 425 448	poor prognosis patients
T4	Participants 576 655	A total of 188 poor prognosis patients recruited in a randomized clinical trial
T5	Participants 927 1014	patients with tumors larger than 7 cm (N = 108) versus tumors 7 cm or smaller (N = 76).
T6	Participants 1606 1693	patients with poor prognosis and inoperable locally advanced non-small-cell lung cancer
T7	Participants 1800 1837	patients with tumors larger than 7 cm
